Donald G. Payan
2013
In 2013, Donald G. Payan earned a total compensation of $1.5M as Executive Vice President, of Discovery and Research at Rigel Pharmaceuticals, a 23% decrease compared to previous year.
Compensation breakdown
| Option Awards | $893,200 |
|---|---|
| Salary | $559,571 |
| Other | $9,906 |
| Total | $1,462,677 |
Payan received $893.2K in option awards, accounting for 61% of the total pay in 2013.
Payan also received $559.6K in salary and $9.9K in other compensation.
Rankings
In 2013, Donald G. Payan's compensation ranked 5,041st out of 12,286 executives tracked by ExecPay. In other words, Payan earned more than 59.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,041 out of 12,286 | 59th |
Division Manufacturing | 1,736 out of 4,612 | 62nd |
Major group Chemicals And Allied Products | 498 out of 1,462 | 66th |
Industry group Drugs | 352 out of 1,156 | 70th |
Industry Pharmaceutical Preparations | 282 out of 890 | 68th |
Source: SEC filing on March 28, 2016.
Payan's colleagues
We found four more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2013.